Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04584710
Recruitment Status : Active, not recruiting
First Posted : October 14, 2020
Last Update Posted : February 9, 2021
Sponsor:
Collaborator:
National Institute on Aging (NIA)
Information provided by (Responsible Party):
Restorbio Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : February 2021
Estimated Study Completion Date : February 2021